Kendall Capital Partners
Boston, Massachusettskcpventures.com
Overview
Kendall Capital Partners is a Boston-based venture capital firm that makes investments in early-stage companies and businesses across the US. The firm primarily focuses on investing in biotech companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Rejuvenate Bio | Jun 2026 | Early Funding | Co-investor |
| Centivax, Inc. | Mar 2026 | Early Funding | Co-investor |
| Centivax, Inc. | Jul 2025 | Series A | Co-investor |
| EpiBone | Nov 2024 | Convertible Debt | Lead |
| General Fluidics Corporation | Jul 2024 | Series B | Co-investor |
Key People
David Zhu
Founding Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.